Federation des caisses Desjardins du Quebec’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Hold |
790
| – | – | ﹤0.01% | 2071 |
|
|
2025
Q1 | $9.39K | Buy |
790
+500
| +172% | +$5.94K | ﹤0.01% | 1982 |
|
|
2024
Q4 | $5.46K | Sell |
290
-700
| -71% | -$13.2K | ﹤0.01% | 2057 |
|
|
2024
Q3 | $22.2K | Sell |
990
-700
| -41% | -$15.7K | ﹤0.01% | 1634 |
|
|
2024
Q2 | $35.3K | Buy |
1,690
+490
| +41% | +$10.2K | ﹤0.01% | 1468 |
|
|
2024
Q1 | $17.6K | Hold |
1,200
| – | – | ﹤0.01% | 1674 |
|
|
2023
Q4 | $12.4K | Hold |
1,200
| – | – | ﹤0.01% | 1702 |
|
|
2023
Q3 | $9.43K | Hold |
1,200
| – | – | ﹤0.01% | 1773 |
|
|
2023
Q2 | $12K | Buy |
1,200
+700
| +140% | +$6.99K | ﹤0.01% | 1703 |
|
|
2023
Q1 | $4.44K | Buy |
+500
| New | +$4.44K | ﹤0.01% | 1939 |
|